Texas Oncology-Grapevine — Grapevine, Texas

Texas Oncology-Grapevine is a clinical research site located in Grapevine, Texas, United States 76051.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology-Grapevine has participated in 14 clinical trials with 5 currently active.

Therapeutic areas: Neoplasms, Cancer, Breast Cancer.

Sponsors: GRAIL, Inc., Agendia, Effector Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grapevine

Browse all research sites in Texas · View every site in Grapevine

• Baylor Scott & White of Grapevine (Hospital)
• Precision Comprehensive Clinical Research Solutions
• Texas Oncology - DFW
• Retina Center of Texas
• Pfizer Investigational Site
• Research Site
• Texas Oncology
• Texas Orthopedic Specialists, PA
• William Blake Partners
• Texas Orthopedic Specialists
• Galderma Investigational Site 7088

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Grapevine?

Texas Oncology-Grapevine has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Grapevine conducted?

Texas Oncology-Grapevine has 14 clinical trials on record, with 5 currently active. Their work covers Neoplasms, Cancer, Breast Cancer.

Is Texas Oncology-Grapevine accredited by Crixeo Clinical Trials?

Texas Oncology-Grapevine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-Grapevine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.